This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Elekta, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Randy Larson - Innovator in Radiation Treatment Planning
Introduction
Randy Larson is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of radiation treatment planning through his innovative ideas and patented technologies. His work focuses on improving the efficiency and effectiveness of radiation therapy for patients.
Latest Patents
Randy Larson holds a patent for a "System and method for radiation treatment planning." This computer-implemented method involves receiving a reference dose value, which is a defined maximum radiation dose within a specific region for radiation treatment in a patient. The method applies an optimization procedure to a treatment plan, aiming to minimize a cost function that represents a dose excess value above the reference dose value. If the dose excess value is determined to be below a threshold, the reference dose value is decreased, and the optimization procedure is reapplied based on this new value.
Career Highlights
Randy Larson is currently associated with Elekta, Inc., a company known for its advanced medical technology solutions. His work at Elekta focuses on enhancing radiation treatment planning, which is crucial for effective cancer therapy. With 1 patent to his name, Larson has established himself as a key player in the field.
Collaborations
Randy has collaborated with talented individuals such as Chunhua Men and Spencer Marshall. These collaborations have contributed to the development of innovative solutions in radiation treatment.
Conclusion
Randy Larson's contributions to radiation treatment planning exemplify the impact of innovation in healthcare. His patented methods are paving the way for more effective cancer treatments, ultimately benefiting patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
